Enrolling Adults in sTMS Clinical Trial for Major Depressive Disorder

What is sTMS?

This investigational treatment, called "Synchronized Transcranial Magnetic Stimulation" (abbreviated "sTMS"), is delivered by a device in the research clinic to patients with Major Depression. The sTMS device (manufactured by NeoSync, Inc.) generates an alternating magnetic field close to a patient's head while they are awake and alert, with synchronization of the magnetic fields delivered to the patient's own brainwave patterns.

Participation

Study participants will be randomly assigned to receive either active sTMS or a series of "sham" (placebo) treatment sessions, for a course of 30 treatments given over a period of 6 weeks. Following completion of all treatment visits, you may be eligible to receive 4 weeks of active sTMS treatment.

Eligibility

Adults ages 22-65 in generally good physical health may be eligible. Additional inclusion and exclusion criteria will be applied during one or more on-site visits.

Potential candidates may call Mood Disorders Research Program clinic staff at (401) 455-6537.